Table 1.
Clinicopathological characteristics of study patients
| Patients (%) | 186 | (100.0) |
|---|---|---|
| Age at diagnosis [years] | ||
| Median (range) | 57 | (26–85) |
| Progression-free survival [months] | ||
| Median (range) | 16 | (1–48) |
| Number of recurrencies (%) | 106 | (57.0) |
| Overall survival [months] | ||
| Median (range) | 24 | (1–49) |
| Number of deaths (%) | 54 | (29.0) |
| Histology (%) | ||
| Serous | 164 | (88.2) |
| Non-serous | 22 | (11.8) |
| FIGO (%) | ||
| II | 9 | (4.8) |
| III | 148 | (79.6) |
| IV | 29 | (15.6) |
| Grading (%) | ||
| 1 | 6 | (3.2) |
| 2 | 43 | (23.1) |
| 3 | 137 | (73.7) |
| Residual disease after initial surgery (%) | ||
| None | 132 | (71.0) |
| ≤ 1 cm | 34 | (18.3) |
| > 1 cm | 20 | (10.8) |
| Type of chemotherapy (%, 30 missing [16.1 %]) | ||
| Adjuvant | 124 | (66.7) |
| Neoadjuvant | 15 | (8.1) |
| Intraperitoneal | 17 | (9.1) |
| Response to first-line chemotherapy (%, 1 missing) | ||
| Responder | 138 | (74.2) |
| Non-Responder | 47 | (25.3) |